Preliminary analysis of the phase II study of pemetrexed plus carboplatin as first-line chemotherapy for elderly patients with advanced nonsquamous, non-small cell lung cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19162-e19162 ◽  
Author(s):  
Naoki Omachi ◽  
Motohiro Tamiya ◽  
Akihiro Tamiya ◽  
Tomoya Kawaguchi ◽  
Hiroyasu Kaneda ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Preliminary Analysis ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Line Chemotherapy

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

Lung Cancer ◽  
2005 ◽  
Vol 47 (3) ◽  
pp. 405-412 ◽  
Author(s):  
Elisabeth Quoix ◽  
Jean-Luc Breton ◽  
Alain Ducoloné ◽  
Bertrand Mennecier ◽  
Alain Depierre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2006 ◽  
Vol 51 (3) ◽  
pp. 357-362 ◽  
Author(s):  
Carmelo Giannitto Giorgio ◽  
Alessandro Pappalardo ◽  
Antonio Russo ◽  
Dario Giuffrida ◽  
Daniele Santini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document